IFT Institut für Therapieforschung

Healthcare Utilization and Direct Medical Costs of Hepatocellular Carcinoma Treatment — A German Claims Data Study of 2778 Patients

Hepatocellular carcinoma (HCC) is a cancer with rising incidence and economic burden. However, evidence on healthcare resource utilization (HCRU) and associated costs is scarce in Europe. This study aims to determine HCRU and costs of HCC from a German third-party payer's perspec...

Use of cannabidiol products in Canada, United States, Australia, Aotearoa New Zealand, United Kingdom and Germany: products, sources and reasons for use

Background Cannabidiol (CBD) has attracted scientific, clinical, and public interest due to its perceived therapeutic benefits and favourable safety profile. However, a gap remains in understanding how different CBD-only regulatory frameworks shape consumers interaction with the...